- Variable efficacy: As with many medical treatments, outcomes can vary between patients. This presents a particular challenge for tech-based treatments, as consumers are accustomed to devices that "just work" for everyone.
Different companies in the neurotech space are taking varied approaches to these challenges. flow Neuroscience, a Swedish medtech company, has opted for a more consumer-oriented approach with their depression-treating wearable. They acknowledge that their transcranial direct current stimulation (tDCS) technology may not work for everyone, but they aim to make it cheap and available to a wide audience.